Prof Andrew Abell
Professor
School of Physics, Chemistry and Earth Sciences
College of Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Andrew graduated from the University of Adelaide with BSc(Hon) and PhD and then undertook a postdoctoral fellowship at the University of Cambridge. He held a professorship at the University of Canterbury before returning to the University of Adelaide in 2007, where he is currently Professor of Chemistry and node director of the ARC Centre of Excellence for Nanoscale Biophotonics. His research interests are concerned with understanding the fundamental link between the chemical structure and shape of key biological molecules and their biological function. While his work is very much driven by fundamental science, he has always had a keen interest in pursuing associated commercial opportunities. The seed for this was sown with a sabbatical leave working as a visiting scientist, consultant and senior Fulbright Fellow with SmithKline Beecham (now GSK) in Philadelphia. In Adelaide he co-founded an Adelaide-based company (Calpain Therapeutics) to develop macrocyclic protease inhibitors as a potential treatment for cataract and other conditions. Past member of ARC College of Experts and Head of School of Chemistry and Physics at the University of Adelaide and also recent recipient of the Royal Australian Chemical Institute Adrien Albert Prize and the Alexander R. Matzuk Prize and Lecture in Drug Discovery (Baylor College of Medicine, Houston).
PROFESSOR ANDREW ABELL
The focus of our extended group is concerned with the design, synthesis, and exploitation of small molecule enzyme inhibitors and mimics of key biological compounds. These compounds provide a basis of new therapeutics for the treatment of cancer and other diseases, as well as probes to study key metabolic processes such as electron transfer. They can also be attached to surfaces to provide functional materials and biosensors.
Please see our Group webpage: https://sciences.adelaide.edu.au/physical-sciences/research/chemistry-research/the-abell-group
Please also see the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP): http://cnbp.org.au/
- PhD, University of Adelaide 1985
- Post-doctoral research fellowship, Cambridge, UK 1985/6
- Lecturer in Chemistry University of Canterbury 1987/94
- Consultant, SmithKline Beecham Pharmaceuticals, USA 1993/4
- Senior Lecturer in Chemistry, University of Canterbury 1994/9
- Director Canterbury Biomedical Research Centre 1999/02
- Associate Professor in Chemistry, University of Canterbury 1999/01
- Professor in Chemistry, University of Canterbury 2001/7
- Adjunct Professor of Chemistry, University of Canterbury 2007-
- Professor in Chemistry, University of Adelaide 2007-
- Adjunct Professor of Chemistry, Lincoln University 2009-
- Head School of Chemistry and Physics, University of Adelaide 2013/4
- Adelaide Node Director Centre for Nanoscale BioPhotonics 2014-
DO YOU WANT TO JOIN OUR GROUP ?
PhD Scholarships
University scholarships for Australian students are known as Australian Postgraduate Awards (APA). These scholarships are awarded on the basis of academic merit and in designated areas of research strength within the University. The University also offers a range of Scholarships for international students.
Further information on PhD scholarships can be found at: http://www.adelaide.edu.au/scholarships/
Postdoctoral Positions
Postdoctoral positions arise from time to time, so if you're interested please get in touch and we'll get back to you ASAP.
- For general postdoctoral scholarships see: Australian Research Council (ARC) and https://www.nhmrc.gov.au/grants-funding
- China - http://www.csc.edu.cn
- Germany - http://www.daad.de
- USA - http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5179&org=OISE&from=fund
PROFESSOR ANDREW ABELL
1. CAREER OVERVIEW
My tertiary education began at the University of Adelaide where I completed a BSc with Honours (1st class, 1982) in chemistry and biochemistry, and a PhD on the chemistry and biochemistry of terpenes (1985). This was followed by a two-year postdoctoral fellowship at Cambridge to work with Professor Sir Alan Battersby on some mechanistic problems in the biosynthesis of vitamin B12 and related pigments. My time at Cambridge provided insights into the process of researching a multidisciplinary problem of considerable breadth and depth. This experience greatly expanded my skills in synthesis, protein science, enzymology, and the supervision of undergraduate and postgraduate students through my association with Pembroke College. At this time it became clear to me that my future was in academia, and with this in mind I accepted a lectureship at the University of Canterbury in 1987.
I quickly established an independent research program at Canterbury working on chemical problems of biological importance, particularly in the area of the design, synthesis and testing of inhibitors of serine proteases. My research group grew in size and stature as I branched into other areas of biological chemistry. One project on the inhibition of HIV protease proved significant for my future career path. We developed an innovative approach to the inhibition of this enzyme and I presented the results of this work at the Royal Australian Institute of Chemistry (RACI) 9th National Conference on Medicinal and Agricultural Chemistry (Melbourne). This attracted the attention of Dr Brian Metcalfe, the then head of medicinal chemistry at SmithKline Beecham (SKB) Pharmaceuticals, Philadelphia, USA (now GSK). I was later offered, and accepted, a sabbatical position to work with SKB in Philadelphia as a visiting scientist, consultant and senior Fulbright scholar for 12 months (1993-4). During this time I was exposed to the workings of a major international pharmaceutical company in what was an ‘eye opening’ experience.
I worked on a number of problems of medicinal importance at SKB, and in the process gained experience in all aspects of drug design and development from project inception, through to synthesis, in vitro and in vivo testing, patent protection, commercialization, management, and large-scale production. My work was concerned with the development of a treatment for conditions associated with an over activity of steroid 5alpha-reductase. This enzyme metabolises testosterone into the more potent androgen, dihydrotestosterone, elevated levels of which are linked to benign prostatic hyperplasia and male pattern baldness. The extended project involved collaboration between chemists, enzymologists and pharmacologists and resulted in the pioneering and development of potent non-steroidal and steroidal inhibitors of the two isozymes of this enzyme. A number of publications and a patent resulted from this work (Abell, A.D., Holt, D.A. International Application No. PCT/US95/04599, 1995) and the research program ultimately released a pharmaceutical, dutasteride. My time in the USA was greatly enhanced by my Fulbright experience, which provided insights into the workings of the USA at the time of the election of Bill Clinton as president. On returning to Canterbury, I continued to work on the steroid reductase problem and in the process developed expertise and international standing in this, and other areas of bioorganic research. At this time I was awarded the New Zealand Institute of Chemistry Easterfield medal. I remain a recognised leader in the area of non-steroidal inhibitors of steroid 5a-reductase.
A good deal of my research efforts now focuses on the design, synthesis and exploitation of small molecule inhibitors and probes of proteases and other biologically important proteins as evidenced in my publication list. This work has advanced a number of bioorganic and surface science-based projects supported by significant external research funding of >$50 million in last 10 years. This funding includes NZ FiRST (equivalent to ARC Linkage), 5 Royal Society of New Zealand Marsden grants (equivalent to ARC DP) and since arriving in Adelaide in 2007; 15 Australian Research Council grants (including ARC Centre of Excellence), three NHMRC grants, as well as funding from commercial sources, Cancer CRC, and medical organisations (see later for detail). In the process I have developed important links with industry, developed and participated in NZ Research Centres of Excellence, and established and nurtured a major collaborative research group located in Adelaide and New Zealand. In late 2011 I co-establishing a company (Calpain Therapeutics) in Adelaide to begin to exploit some of our research. We have also recently developed a potentially new first in class antibiotic based on the inhibition of Biotin Protein Ligase. In 2012 I was awarded the Adrien Albert Prize. This is the premier award of the Division of Biomolecular Chemistry of the Royal Australian Chemical Institute (RACI) and is given for sustained, outstanding research in the field of medicinal or agricultural chemistry, related to biomolecular chemistry. I was also the recipient of the Alexander R. Matzuk Prize and Lecture in Drug Discovery, (Dec 2013). This international prize was developed with support from the Department of Pathology & Immunology at Baylor College of Medicine, the Burroughs Wellcome Fund, and the Matzuk and Zechiedrich families. I am also currently the Adelaide node leader of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP, see http://cnbp.org.au/), a past head of School of Chemistry and Physics (Uni of Adelaide) and recently co-established a USA-based company - ImmuniLogic.
I have supervised in excess of 80 PhD students and 50 post-doctoral fellows in the last 20 years alone, with many now occupying influential academic and industrial positions around the globe. I am pleased to say that I have a 100% completion rate on student supervisions and have >250 career supervisions. In recognition of my standing and achievements I was promoted to full Professor at the University of Canterbury in 2001. In 2007, I was offered (by the Vice Chancellor, Prof James McWha) and accepted a tenured Professorship at the University of Adelaide. I was also offered a chair of Oenology at the University of Adelaide and a Professorship at the University of South Australia, but these positions were declined in favour of my current appointment. I retain adjunct Professorships at the University of Canterbury and Lincoln University, was appointed to the ARC College of Experts, and I am a past Head of School of Chemistry and Physics at the University of Adelaide. I also served three terms an elected member of the University of Adelaide Council and as an Australian Fulbright Ambassador.
2. RESEARCH LEADERSHIP AND STANDING
My international research profile has resulted in membership of overseas delegations, committees and collaborations (see later for detail), numerous invited and in-person plenary lectures; most recently RACI conventions (Brisbane and Wollongong, 2022), Symposium on Electronic and Coupled Transport in Biology, Boston Fall MRS meeting (Boston, 2018), RACI Medicinal Chemistry and Chemical Biology Conference (Brisbane, 2018), RACI Organic Divisional Meeting (Perth, 2018), University of Strasbourg (France 2017), USA Air force Life Sciences Program Review (Dayton Ohio), the Queenstown Molecular Biology Meeting (Shanghai), Alexander R. Matzuk Lecture in Drug Discovery (Baylor College, Houston), RACI Adrien Albert address (Leura, NSW), RACI Biomolecular division conference (Torquay) and ‘Calpain FASEB Summer Research Conference’ Carefree, Arizona; ‘International Symposium on Olefin Metathesis’, Pasadena USA, as organised by Professor Grubbs the joint 2005 Nobel Laureate for work on metathesis; ‘surface attachment of peptides and peptidomimetics’. I am a member of editorial and advisory boards (e.g. Governing Board of NZ Chemical Genetics consortium; Editorial board of ‘Protein and Peptide Letters’, ‘Medicinal Chemistry Reviews’, and ‘Mini Reviews in Medicinal Chemistry’ and ‘Perspectives in Medicinal Chemistry, Asian Chem Letters, and others), secondment to industry, and invitations to apply for influential chairs around the globe. I have also organized a number of international meetings, most notably the Pacifichem Heterocyclics Symposium Hawaii; Chairperson of the 2003 NZIC convention; 5th and 6th International Peptide Conferences. Standing in my field is apparent with my appointment to the Australian Research Council (ARC) College of Experts (2011-) and a number of awards and honours as detailed in my accompanying CV. In addition to these activities I have been employed as a visiting scientist and consultant by SmithKline Beecham Pharmaceuticals (USA) and by Eli Lilly and Biogen USA Pharmaceuticals (USA) as an expert witness in international court cases concerned with patent infringement.
In 2004 co-initiated collaboration between the University of Canterbury, Lincoln University and Douglas Pharmaceuticals, to design and develop a pharmaceutical-based treatment for cataract based on the inhibition of calpain. Our extended team designed, developed, and tested an efficacious lead structure, however with my move to Adelaide in 2007 the project somewhat stagnated. With this realisation, Dr Tim Lovell (BioInnovationSA, Adelaide) and I established an Adelaide-based company (Calpain Therapeutics: http://calpaintherapeutics.com/) to commercialise the lead structure and to take advantage of the associated opportunity. Calpain Therapeutics was named the 2011 winner of The University of Queensland Business School's Enterprize competition and it has subsequently received considerable media attention. The wider aspects of this project currently account for approximately one third of my research effort, with significant external funding since its inception to support a team of researchers at the University of Canterbury, Lincoln, Douglas and now the University of Adelaide. During the course of the project we have developed and established expertise in computer-based inhibitor design, synthesis, drug formulation, delivery, and in vitro and in vivo testing. Patents have been granted and we successfully negotiated transfer and future licensing of the most important IP from Adelaide to Calpain Therapeutics. The project has identified a number of new and particularly potent, peptidomimetic-based compounds that show excellent anti-cataract activity in vitro, in lens culture, and also in in vivo-based animal trials. I significant amount of my current time is spent coordinating and balancing these activities, with academic and industrial partners and business interests. On moving to Adelaide, I extended this research into the new areas of traumatic brain injury, stroke and the inhibition of the proteasome and cathepsins as potential treatments for some cancers; and also a fundamental study into the processes of electron transfer with applications in molecular electronics. This significant endeavour has provided invaluable experience in coordinating and balancing fundamental research, involving a number of disciplines, with commercial interests and their associated demands.
A good deal of my other current research time is spent on research projects at the interface of chemistry, biochemistry and surface science. Projects include the development of inhibitors of the shikimate pathway as potential herbicides and antibacterial agents (collaboration with the University of Cambridge), the immobilization of peptides and peptidomimetics on surfaces as a basis for new functional materials to study electron transport at the most fundamental level, and biosensors in collaboration with the Institute for Photonics and Advanced Sensing (IPAS, see http://www.adelaide.edu.au/ipas/) and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP, see http://cnbp.org.au/) (Marsden and ARC funded), the control of peptide and protein conformation through stereoelectronic effects (ARC funded), and recently the design and synthesis of inhibitors of Biotin Protein Ligase (BPL) as new antibacterial agents (NHMRC, CAS and private funding). This last project has already yielded a new class of inhibitor of Staphylococcus aureus that shows significant activity and promise against clinical strains of these bacteria and again efforts are underway to commercialise the outcomes. A number of high-profile publications have recently been accepted and are in preparation based on this project.
A particularly important theme in much of our work has been the development of olefin metathesis and more recently ‘click’ chemistry for the preparation and surface immobilisation of peptide like structures. Much of this work began with our publication of an invited review [Ring-closing Metathesis of nitrogen-containing compounds: applications to heterocycles, alkaloids and peptidomimetics; A. J. Phillips and A. D. Abell, Aldrichimica Acta, 1999, 32(3), 75-89]. This land-mark paper was one of the first to propose the importance of metathesis chemistry to the area of peptides and peptidomimetics, and it continues to be very well cited (>350 citations to date). Our metathesis work also offers significant potential for surface attachment studies, and for conjugating biomolecules onto active ligands and macrostructures to access important immunoconjugates, peptide-sugars, and biosensors. In order to fully exploit this we need access to metathesis catalysts that are active in aqueous conditions. Collaborative ARC-funded research was undertaken with the GKSS in Germany and Professor Bob Grubbs (2005 joint Nobel laureate for metathesis) to extend metathesis to an aqueous environment. Some of this work was present in an invited lecture at the ‘International Symposium on olefin metathesis’, Pasadena USA and we recently published a number of papers on this topic. A number of ARC funded research project concerned with the design and synthesis of peptide-like structures constrained into a beta-strand or helical geometry have also been progressed through collaboration with Professor Seebach at the ETH.
Since moving to Adelaide in 2007 I have grown a significant research group with postdoctoral fellows from Germany (DAAD funded), Switzerland (ARC international fellow), Belgium, China, Denmark, New Zealand, USA, India, Singapore, Spain, and Australia; as well as more than 70 PhD students and 50 honours students. Significant new research is being undertaken through collaboration with Adjunct Professor John Wallace of the School of Molecular and Biomedical Science, Professor Irene Hudson (now University of Newcastle and RMIT), Monash University, RMIT, Macquarie University, Chinese Academy of Sciences Beijing, ETH, Bonn, GKSS, CalTech, and with Professor Tanya Monro through the establishment and growth of the Institute for Photonics and the Advanced Sensing and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP). This major multidisciplinary research institute ($40,000,000 funding over 7 years) is directed at discovering new approaches to measure nano-scale dynamic phenomena in living system, see http://cnbp.org.au/ for detail. Our most recent and exciting work has identified a new targeted treatment for Neuropathic pain and if funded by a significant grant from the NIH (USA).
The results of my research have been published in more than 350 high impact international publications, book chapters, reviews and patents with presentations at many international meetings and institutions. I am also a past editor of two volumes of an acclaimed series on ‘Peptidomimetics’. See JACS, 1998, p10276, DOI:10.102/ja985644+ for an independent review.
3. RECENT IN PERSON PLENARY AND MAJOR INVITED LECTURES
RACI Organic and Medicinal Chemistry Conference - OMC2022 (Wollongong, 2022), RACI National Congress (Brisbane, 2022), ICOB 2019 (St Andrews, 2019), Symposium on Electronic and Coupled Transport in Biology, Boston Fall MRS meeting (Boston, 2018), RACI Medicinal Chemistry and Chemical Biology Conference (Brisbane, 2018), RACI Organic Divisional Meeting (Perth, 2018), University of Strasbourg (France 2017), USA Air force 2016 Life Sciences Program Review (Dayton Ohio, 2016), Queenstown Molecular Biology Meeting (Shanghai, March 2016), Alexander R. Matzuk Lecture in Drug Discovery (Baylor College, Houston), Royal Australian Chemical Institute Adrien Albert address (Leura, NSW), NZIC convention (Waikato); RACI Biomolecular division conference (Torquay); (Calpain FASEB Summer Research Conference (Carefree, Arizona, 2010); Royal Australian Chemical Institute Organic Conference (Hobart Australia, 2008); Southern Highlands Heterocyclic Symposium, Sydney (2008), Invited lecture to ‘International Symposium on olefin metathesis’, (Pasadena USA, 2007), Keynote lecture to ‘Drug design amongst the vines’ RACI meeting (Sydney, Dec 2006), 2005 International Chemical Congress of Pacific Basin Societies (Hawaii, 2005); 1st Asia-Pacific International Peptide Symposium (Fukuoka, Japan, Nov 2004); 19th Royal Australian Chemical Institute Organic Conference (Lorne Australia, Plenary lecture 2003); 5th Australian Peptide Conference (Daydream Island, Oct 5-10, 2003); University of Otago collaboration series (2002); NZIC National Convention (Napier, 2001); 4th Australian Peptide Conference (Lindeman Island, 2001); 2000 International Chemical Congress of Pacific Basin Societies (Hawaii, 2000). 6th International Conference for AIDS Cancer and Related Problems (St Petersburg, Russia); New Zealand Institute of Chemistry Easterfield lecture; University of Melbourne Synthesis Symposium (Plenary lecture); Universities of Singapore, Melbourne, Sydney, RMT, Macquarie University, Monash, Newcastle, Canterbury, Lincoln, Cambridge, Edinburgh, Tokyo, Gratz, ETH, Yale, Pittsburg, ANU, Melbourne, Queensland, Wollongong, Otago
4. PROFESSIONAL SERVICE
In addition to the research and associated activities described above, I have extensive experience and interest in academic management and administration at the department, university, national and international levels. I am the current Adelaide node director of the Centre for Nanoscale BioPhotonics (CNBP, see http://cnbp.org.au/), recent member of the University of Adelaide Council and past head of School of Chemistry and Physics at the University of Adelaide and head of Biochemistry at the University of Canterbury. These duties have provided me with an intimate knowledge and understanding of all levels of University administration. I was also an active member and contributor to many of major institutional committees; including academic board, university research committee, standing committee, academic promotions committee, and the foundation board of health. This last committee was charged with leading the universities expansion into health related disciplines.
I have been intimately involved in a number of other major research institutes and centres over the last 15 years. I was the founding director of a Research Centre at The University of Canterbury (1999-2001) with members from several university departments and Canterbury-based research organizations. This centre successfully attracted significant external funding and established multidisciplinary links throughout the university and the wider Canterbury region. This development, and my association with other university wide research activities, led to my involvement with Canterbury Health Laboratories and Crown Research Institutes (Government funded organizations analogous to the CSIRO). I remain a member of two New Zealand CoRE centres of excellence (The MacDiarmid Institute for Advanced Materials and Nanotechnology http://www.macdiarmid.ac.nz/ and the Maurice Wilkins Centre for molecular biodiscovery <http://www.mauricewilkinscentre.org/>), which were established to act as national centres of research excellence. On moving to Adelaide, I was involved in a successful Australian Federal Government HEEF application (2008), which received $28.8 million to help build a new centre for Photonics and Surface Science (IPAS). This building is part of a major new initiative established to create an interactive and integrated research and teaching environment of national and international significance, see http://www.adelaide.edu.au/ipas/. Much has been done to establish and develop this centre, including securing extended funding and opportunity and through the coordination of stakeholders, architects, and consultants. I now occupy the synthetic and surface science capability and laboratories in IPAS and the ARC Centre of Excellence for Nanoscale BioPhotonics, of which I am a CI and the Adelaide node leader
I have also served on numerous national and international review and granting bodies in recent times, including European Commission Marie Skłodowska Curie – Individual Fellowship (2016-22), ARC College of Experts (2011-14), European Union Funding Framework (Brussels), Australian National Health and Medical Research Council Program Grant Committee, the Royal Society of New Zealand Marsden Fund, and the Canterbury PBRF committee I have also spent time with the New Zealand Ministry of Research Science & Technology (MoRST) in Wellington. These experiences have enabled me to develop important links with major funding bodies and organizations. While at Canterbury, I was also a member of a high-level New Zealand government funded delegation that visited the Riken Institute in Japan (http://www.riken.jp/engn/) to develop joint programs of research and collaboration in the area chemical genetics. This culminated in the establishment of a NZ Chemical Genetics consortium, of which I was a member of the Governing Board.
Since arriving in Adelaide in 2007 I have also gained an intimate knowledge of the workings of the Australian Research Council (ARC), through my role on the College of experts, but also through developing successful multidisciplinary applications for LIEF, Linkage, SuperScience and discovery and Centre of Excellence funding. All this has required leadership and an ability to coordinate varied interests, expectations, and personalities across different disciplines and institutions. We have also developed significant collaborative funding opportunities through NHMRC, International Science Linkages (China), and commercial ventures as detailed elsewhere in this document. Most recently I was appointed an Australian Fulbright Ambassador and I am currently the University of Adelaide Honours Chemistry Coordinator.
| Date | Position | Institution name |
|---|---|---|
| 2014 - ongoing | Adelaide Node Leader | Centre for Nanosale BioPhotonics (CNBP) |
| 2013 - 2014 | Head of School of Chemistry and Physics | The University of Adelaide |
| 2011 - ongoing | Chief Scientific Advisor | Calpain Therapeutics |
| 2007 - ongoing | Professor | University of Adelaide |
| 2007 - ongoing | Adjunct Professor | University of Canterbury |
| 2007 - ongoing | Adjunct Professor | Lincoln University (New Zealand) |
| 2001 - 2007 | Professor | University of Canterbury |
| 1993 - 1994 | Visiting Scientist and Fulbright Scientist | SmithKline Beecham |
| 1985 - 1987 | Postdoctoral Fellow | University of Cambridge |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2022 | Distinction | NIH funding | University of Adelaide | United States | - |
| 2022 | Achievement | coestablished USA-based company | Immunologic | United States | - |
| 2017 | Distinction | Visiting Professorship | University of Strasbourg | France | - |
| 2017 | Honour | Visiting Professor University of Strasbourg | - | - | - |
| 2016 | Distinction | Funding Body | European Union Funding Framework | Belgium | - |
| 2015 | Award | University of Queensland (UQ) Business-School Enterprize Award | University of Queensland | Australia | - |
| 2015 | Achievement | Calpain Therapeutics, chief Acientific Officer | Calpain Therapeutics Company | Australia | - |
| 2013 | Award | Alexander R. Matzuk Prize and Lecture in Drug Discovery | - | - | - |
| 2013 | Achievement | consultancy | Minter Ellison | Australia | - |
| 2013 | Achievement | Founding member of the Institute for Photonics and Advanced Sensing | University of Adelaide | Australia | - |
| 2012 | Award | Adrien Albert Prize | - | - | - |
| 2011 | Award | The University of Queensland Business School's Enterprize | - | - | - |
| 2010 | Distinction | Adjunct Professor at the University of Canterbury Lincoln University | - | - | - |
| 2007 | Distinction | Fellow of Royal Australian Institute of Chemistry | - | - | - |
| 2007 | Honour | Adjunct Professor at the University of Canterbury | - | - | - |
| 2004 | Distinction | Elected Member of the New Zealand Centre for Molecular Biodiscovery CoRE | - | - | - |
| 2003 | Fellowship | University of Canterbury Erskine Fellowship | - | - | - |
| 2002 | Distinction | Elected member of the New Zealand MacDiarmid Institute for Advanced Materials and Nanotechnology CoRE | - | - | - |
| 2001 | Fellowship | University of Canterbury Erskine Fellowship | - | - | - |
| 2000 | Honour | Elected member of the American Chemical Society | - | - | - |
| 2000 | Distinction | American Chemical Society Member | American Chemical Society (ACS) | United States | - |
| 1999 | Distinction | University of Canterbury Academic Board | University of Canterbury | New Zealand | - |
| 1998 | Award | Royal Society of Chemistry Journals Grants for international Authors | - | - | - |
| 1997 | Invitation | Invited Editor for JAI Press, London and Connecticut | - | - | - |
| 1995 | Award | Easterfield medal | - | - | - |
| 1995 | Distinction | Fellow of New Zealand Institute of Chemistry (FNZIC) | - | - | - |
| 1993 | Award | Fulbright Fellow | - | - | - |
| 1993 | Distinction | Visiting Scientist and Consultant SmithKline Beecham Pharmaceuticals USA | SmithKline Beecham | United States | - |
| 1985 | Research Award | George Murray Scholarship | - | - | - |
| 1981 | Award | C.S.R. Chemicals Prize | - | - | - |
| Year | Citation |
|---|---|
| 2020 | Hudson, I. L., Leemaqz, S. Y., & Abell, A. D. (2020). Machine learning and scoring functions (SFs) for molecular drug discovery: Prediction and characterisation of druggable drugs and targets. In H. M. Cartwright (Ed.), Machine Learning in Chemistry: The Impact of Artificial Intelligence (Vol. 17, pp. 251-279). Croydon; United Kingdom: Royal Society of Chemistry. DOI |
| 2017 | Horsley, J., Yu, J., Yeoh, Y., & Abell, A. (2017). Peptides as bio-inspired molecular electronic materials. In A. Sunna, A. Care, & P. L. Berquist (Eds.), Peptides and Peptide-based Biomaterials and their Biomedical Applications (Vol. 1030, pp. 131-153). Switzerland: Springer, Cham. DOI Scopus1 |
| 2017 | Abell, A. D., & Pehere, A. D. (2017). The Synthesis of Peptide-Based Macrocycles by Huisgen Cycloaddition. In E. Marsault, & M. L. Peterson (Eds.), Practical Medicinal Chemistry with Macrocycles: Design, Synthesis, and Case Studies (pp. 265-280). Hoboken, New Jersey; USA: John Wiley & Sons. DOI Scopus1 |
| 2016 | Hudson, I., Leemaqz, S., Neffe, A., & Abell, A. (2016). Classifying calpain inhibitors for the treatment of cataracts: A self organising map (SOM) ANN/KM approach in drug discovery. In S. Shanmuganathan, & S. Samarasinghe (Eds.), Artificial Neural Network Modelling (Vol. 628, 1 ed., pp. 161-212). Switzerland: Springer. DOI Scopus2 |
| 2013 | Abell, A., & Pehere, Ashok D.. (2013). Macrocyclic Protease Inhibitors Constrained into a β-Strand Geometry. In S. Chakraborti, & N. S. Dhalla (Eds.), Proteases in Health and Disease (pp. 181-192). Springer. DOI Scopus5 |
| 2013 | Pehere, A. D., & Abell, A. D. (2013). Macrocyclic Protease Inhibitors Constrained into a β-Strand Geometry. In Advances in Biochemistry in Health and Disease (Vol. 7, pp. 181-192). DOI |
| 2011 | Pedersen, Daniel Sejer., & Abell, A. (2011). Huisgen cycloaddition in peptidomimetic chemistry. In Hughes, Andrew B (Ed.), Amino Acids, Peptides and Proteins in Organic Chemistry, Protection Reactions, Medicinal Chemistry, Combinatorial Synthesis (Vol. 4, pp. 99-127). Wiley. DOI Scopus8 |
| 2009 | Abell, A. D., & Edmonds, M. (2009). Synthesis using the Wittig and related Phosphorus-, Silicon-, or Sulfur-based reactions.. In V. H. Rawal (Ed.), Science of Synthesis (Vol. 46). Thieme Chemistry. |
| 2004 | Abell, A., & Edmonds, M. (2004). Wittig and related reactions. In P. Murphy (Ed.), Organophosphorus Reagents: A Practical Approach in Chemistry (pp. 99-126). Oxford: Oxford University Press. |
| 2004 | Edmonds, M., & Abell, A. (2004). The Wittig Reaction. In Takeshi Takeda (Ed.), Modern Carbonyl Olefination: Methods and Applications (1 ed., pp. 1-16). VCH: Wiley. DOI Scopus61 |
| 1999 | Abell, A. D. (1999). Advances in Peptidomimetics and amino acid mimics. In A. D. Abell (Ed.), Peptidomimetics and amino acid mimics (pp. 300 pages). JAI Press,. |
| 1997 | Abell, A. D. (1997). Advances in Peptidomimetics and amino acid mimics. In A. D. Abell (Ed.), Advances in Peptidomimetics and amino acid mimics (pp. 3002 pages). JAI Press. |
| 1997 | Abell, A. D. (1997). Advances in Peptidomimetics and amino acid mimics. In A. D. Abell (Ed.), Advances in Peptidomimetics and amino acid mimics (pp. 3002 pages). JAI Press. |
| 1995 | Abell, A. D., & Taylor, J. M. (1995). Dimethyl bis(methylthio)methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2031-2033). John Wiley and Son). |
| 1995 | Abell, A. D. (1995). Triethyl phosphonoacetate.. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 5116-5118). John Wiley and Son. |
| 1995 | Abell, A. D., & Taylor, J. M. (1995). Trimethyl phosphonoacetate.. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 5220-5223). John Wiley and Son. |
| 1995 | Abell, A. D. (1995). Dimethyl methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2098-2110). John Wiley and Son. |
| 1995 | Abell, A. D., & Taylor, J. M. (1995). Dimethyl bis(methylthio)methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2031-2033). John Wiley and Son. |
| 1995 | Abell, A. D., & Taylor, J. M. (1995). Dimethyl bis(methylthio)methylphosphonate. In L. A. Paquette (Ed.), Encyclopedia of Reagents for Organic Synthesis (pp. 2031-2033). John Wiley and Son. |
| 1991 | Abell, A. D. (1991). Latent reactivity: The study of enzyme mechanisms and the design of enzyme inactivators. In J. M. Coxon (Ed.), Advances in Detailed Reaction Mechanisms (Vol. 2, pp. 243-278). JAI Press,. |
| Year | Citation |
|---|---|
| 2024 | Bursill, C., Sandeman, L., Layland, M., Lee, D., Nankivell, V., Tan, J., . . . Abell, A. (2024). DIROXIMEL FUMARATE REDUCES ATHEROSCLEROTIC PLAQUE SIZE AND INSTABILITY. In ATHEROSCLEROSIS Vol. 399 (pp. 2 pages). OMAN, Muscat: ELSEVIER IRELAND LTD. DOI |
| 2021 | Li, J., Capon, P. K., Horsfall, A. J., Yagoub, S., Schartner, E. P., Khalid, A., . . . Abell, A. D. (2021). Single-fiber-based probe for combined imaging and pH sensing. In Proceedings of the 2021 IEEE Photonics Conference (IPC 2021) (pp. 1-2). online: IEEE. DOI |
| 2019 | Sylvia, G. M., Schartner, E. P., McLennan, H. J., Saini, A., Dunning, K. R., Purdey, M. S., . . . Thompson, J. G. (2019). High precision pH measurements in biological environments using a portable optical fibre pH sensor. In E. M. Goldys, & B. C. Gibson (Eds.), Biophotonics Australasia 2019 Vol. 11202 (pp. 112020F-1-112020F-2). Bellingham, Washington: SPIE. DOI |
| 2019 | Hudson, I., Leemaqz, S., & Abell, A. (2019). Artificial neural networks & random forest classification of druggable molecules and disease targets via scoring functions (sfs). In 23rd International Congress on Modelling and Simulation - Supporting Evidence-Based Decision Making: The Role of Modelling and Simulation, MODSIM 2019 (pp. 28-34). online: Modelling & Simulation Society of Australia & New Zealand Inc. Scopus1 |
| 2017 | Kostecki, R., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2017). Liposome functionalization of microstructured optical fiber as ion biosensor. In Proceedings of SPIE - The International Society for Optical Engineering Vol. 10604 (pp. 42-43). Cyprus: SPIE. DOI |
| 2017 | Hudson, I., Leemaqz, S., Shafi, S., & Abell, A. (2017). Score function of violations and best cutpoint to identify druggable molecules and associated disease targets. In Proceedings - 22nd International Congress on Modelling and Simulation, MODSIM 2017 (pp. 487-493). online: MSSANZ. Scopus3 |
| 2016 | Peddie, V., Heng, S., Mustafa, S., Thomas, J., Hutchinson, M., & Abell, A. (2016). Shapeshifting photoswitchable azobenzene compounds and their biological applications. In M. Hutchinson, & E. Goldys (Eds.), Proceedings of SPIE - The International Society for Optical Engineering Vol. 10013 (pp. 4 pages). Adelaide, AUSTRALIA: SPIE-INT SOC OPTICAL ENGINEERING. DOI |
| 2016 | Kumeria, T., Yu, J., Alsawat, M., Kurkuri, M., Santos, A., Abell, A., & Losic, D. (2016). Modulating molecular transport across peptide-modified nanoporous alumina membranes with light. In M. Hutchinson, & E. Goldys (Eds.), Proceedings: SPIE BioPhotonics Australasia Vol. 10013 (pp. 100131W-1-100131W-6). Adelaide, Australia: SPIE. DOI Scopus2 WoS2 |
| 2016 | Sylvia, G., Heng, S., & Abell, A. (2016). Fluorescence enhancement of photoswitchable metal ion sensors. In M. Hutchinson, & E. Goldys (Eds.), Proceedings: SPIE BioPhotonics Australasia Vol. 10013 (pp. 100131X-1-100131X-9). Adelaide, Australia: SPIE. DOI Scopus1 WoS1 |
| 2016 | Zhang, P., Ruan, S., Zhang, R., Pullen, B., Zhang, X., Purdey, M., . . . Ruan, Y. (2016). Nitric oxide sensitive optic fiber sensor based on immobilized ruthenium(II) complex. In Optics InfoBase Conference Papers Vol. Part F37-APOS 2016 (pp. 1-3). Online: OSA Publishing. DOI |
| 2016 | Purdey, M., Saini, A., McLennan, H., Pullen, B., Schartner, E., Sutton-McDowall, M., . . . Abell, A. (2016). Biosensors for detecting stress in developing embryos. In M. Hutchinson, & E. Goldys (Eds.), Proceedings: SPIE BioPhotonics Australasia Vol. 10013 (pp. 100130B-1-100130B-6). US: SPIE. DOI Scopus1 WoS1 |
| 2015 | da Costa, T. P. S., Tieu, W., Abell, A. D., Polyak, S. W., & Booker, G. W. (2015). "Humanised" biotin protein ligase provides clues about inhibitor selectivity. In FEBS JOURNAL Vol. 282 (pp. 143). Berlin, GERMANY: WILEY-BLACKWELL. WoS2 |
| 2015 | Purdey, M., Schartner, E., Sutton-McDowall, M., Ritter, L., Thompson, J., Monro, T., & Abell, A. (2015). Localised hydrogen peroxide sensing for reproductive health. In F. Baldini, J. Homola, & R. Lieberman (Eds.), Proceedings of SPIE, as published in Optical Sensors Vol. 9506 (pp. 950614-1-950614-10). US: SPIE. DOI Scopus6 WoS2 |
| 2015 | Purdey, M., Schartner, E., Monro, T., Aitken, R., Thompson, J., & Abell, A. (2015). Hydrogen peroxide sensing for reproductive health. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Vol. 249 (pp. 1 page). AMER CHEMICAL SOC. |
| 2015 | Pehere, A., Pietsch, M., Paul, N., Callen, D., Gutschow, M., & Abell, A. (2015). Design, synthesis, and testing of macrocyclic β-strand as protease inhibitors. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Vol. 249 (pp. 1 page). AMER CHEMICAL SOC. |
| 2014 | Neffe, A., Chua, K., Luetzow, K., Pierce, B., Lendlein, A., & Abell, A. (2014). Crosslinking of gelatin by ring opening metathesis under aqueous conditions - an exploratory study. In A. Lendlein, & M. Behl (Eds.), Polymers for Advanced Technologies Vol. 25 (pp. 1371-1375). Berlin: John Wiley & Sons. DOI Scopus4 WoS4 |
| 2014 | Kostecki, R., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2014). Functionalization of exposed core fibers with multiligand binding molecules for fluorescence based ion sensing. In J. Lopez-Higuera, J. Jones, M. Lopez-Amo, & J. Santos (Eds.), Proceedings of SPIE - The International Society for Optical Engineering Vol. 9157 (pp. 915788-1-915788-4). US: SPIE. DOI Scopus2 WoS1 |
| 2013 | Heng, S., Nguyen, M. C., Kostecki, R., Monro, T., & Abell, A. (2013). Nanoliter-scale, regenerable ion sensor: Sensing with surface functionalized microstructured optical fiber. In Optical Sensors 2013 Vol. 8774 (pp. 29493-29504). United States: SPIE. DOI Scopus3 WoS3 |
| 2013 | Zafar, S., Cheema, S., Beh, E., Hudson, I., Hudson, S., & Abell, A. (2013). Linking ordinal log-linear models with Correspondence Analysis: an application to estimating drug-likeness in the drug discovery process. In J. Piantadosi, R. Anderssen, & J. Boland (Eds.), 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013) (pp. 1945-1951). Adelaide, AUSTRALIA: MODELLING & SIMULATION SOC AUSTRALIA & NEW ZEALAND INC. Scopus8 WoS4 |
| 2009 | Schartner, E., Pietsch, M., Abell, A., & Monro, T. (2009). A hydrogen peroxide fibre optic dip sensor for aqueous solutions. In Proceedings of the ACOLS ACOFT 09 Conference (pp. 61-62). CDROM: Australian Optical Society. |
| 2008 | Schartner, E. P., Monro, T. M., Ebendorff-Heidepriem, H., Pietsch, M., Abell, A. D., Hulston, C., & Davis, C. (2008). Fuel degradation sensing using microstructured optical fibres. In Materials Forum Vol. 33 (pp. 267-278). |
| 2005 | Vernall, A. J., & Abell, A. D. (2005). Cross-metathesis reactions of amino acids. In M. Flegel, M. Fridkin, C. Gilon, & J. Slaninova (Eds.), Peptides 2004, Proceedings (pp. 283-284). Prague, CZECH REPUBLIC: KENES INT. |
| 2004 | Anderson, K., Gardiner, J., & Abell, A. (2004). Conformationally constrained beta-amino acids. In Peptides 2004 : proceedings of the third international and twenty-eighth European peptide symposium (pp. 409-410). Prague, Czech Republic: KENES INT. |
| 2003 | Abell, A. (2003). Lectures presented at the 14th international conference on organic synthesis (ICOS-14), Christchurch, New Zealand, 14-18 July 2002: Preface. In Pure and Applied Chemistry Vol. 75. |
| 2003 | Gower, M. A., Le Sann, C., & Abell, A. D. (2003). Synthesis of shikimate pathway inhibitors as potential antimicrobial agents.. In ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Vol. 226 (pp. U64). NEW YORK, NEW YORK: AMER CHEMICAL SOC. |
| 2000 | Harvey, A. J., & Abell, A. D. (2000). Azobenzene-containing, peptidyl α-ketoesters as photobiological switches of α-chymotrypsin. In Tetrahedron Vol. 56 (pp. 9763-9771). PERGAMON-ELSEVIER SCIENCE LTD. DOI Scopus69 WoS68 |
| Year | Citation |
|---|---|
| 2018 | Pei, J. V., Heng, S., De Ieso, M., Sylvia, G., Kourghi, M., Abell, A. D., & Yool, A. J. (2018). Real-Time Imaging of Lithium 'Hot-Spots': An Analysis of Ion Conductance in Aquaporin-1 using Novel Photo-Switchable Sensor. Poster session presented at the meeting of BIOPHYSICAL JOURNAL. San Francisco, CA: CELL PRESS. |
| 2015 | Kostecki, R., Heng, S., Ebendorff-Heidepriem, H., Abell, A., & Monro, T. (2015). Thin-Film Polymer Functionalization of Optical Fiber Enabling Multiligand Chemosensing. Poster session presented at the meeting of The Materials in Society Lecture Series. Singapore. |
| 2012 | Keeling, K., Abell, A., Wegner, K., Booker, G., Scanlon, D., & Martin, L. (2012). Targeting protein-protein interactions using small peptides for treatment of disease. Poster session presented at the meeting of JOURNAL OF PEPTIDE SCIENCE. WILEY-BLACKWELL. |
| Year | Citation |
|---|---|
| 2018 | Authors: Wegener K, Mcgrath A, Dixon N, Oakley A, Scanlon D, Abell A, Bruning J. Title: Rational Design of a 310-Helical PIP-Box Mimetic Targeting PCNA, the Human Sliding Clamp [Cover Profile]. Extent: N/A. DOI |
| Year | Citation |
|---|---|
| 2015 | Wallace, J., Morona, R., Polyak, S., Booker, G., Abell, A., & Wilce, M. (2015). 9108978, Novel Antimicrobial Compounds. United States of America. |
| 2006 | Abell, A., Neffe, A., Stuart, B., Lee, H., Morton, J., Coxon, J., . . . Aitken, S. (2006). 550631, Compounds and compositions. New Zealand. |
| 2006 | Abell, A., Neffe, A., Stuart, B., Lee, H., Morton, J., Coxon, J., . . . Aitken, S. (2006). 547303, Calpain inhibitors and compositions. New Zealand. |
| 1995 | Abell, A. D. (1995). PCT/US95/04599, Diazo-phenanthrenone-based inhibitors of steroid 5-alpha reductase. Abell, A.D., Holt, D.A. International Application No. PCT/US95/04599, 1995.. |
| Year | Citation |
|---|---|
| 2018 | Schumann, N. C. (2018). Inhibition of Serine and Cysteine Proteases by Peptidomimemtic Inhibitors. (Master's Thesis, University of Adelaide). |
| Year | Citation |
|---|---|
| 2025 | Emery, A., Blaschuk, O. W., Dinh, D. T., McPhee, T., Becker, R., Abell, A. D., . . . Russell, D. L. (2025). N-cadherin mechanosensing in ovarian follicles controls oocyte maturation and ovulation. DOI WoS3 Europe PMC5 |
| 2024 | Singh, A. K., Ruiz, D., Rasheed, M. S. U., Avery, T. D., Turner, D. J. L., Abell, A. D., & Grace, P. M. (2024). Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice.. DOI |
Major recent research grants and funding
- 1993-1997: PGSF funding, Synthetic and Natural Products as a Source of Pharmaceuticals ($910,000).
- 1996-1998: Three year funding in the inaugural round of the NZ Marsden fund ($59,000).
- 1998: The Agriculture and Marketing Research and Development Trust (AGMARDT) funding (PhD fellowship).
- 1998: Two year FORST postdoctoral funding ($140,000).
- 1998: Royal Society of Chemistry International Authors Travel Grant.
- 1999-2002: Chief Investigator A, Royal Society of NZ Marsden award. Molecular Switches and the Modulation of Chemical Reactivity and Enzyme Action ($323,000).
- 1999: University of Canterbury Research Grant, The Design and Synthesis of HIV Protease Inhibitors ($28,020).
- 2001-2003: Chief Investigator A, Royal Society of NZ Marsden award. Design and Synthesis of Shikimate Pathway Inhibitors ($475,000).
- 2002-2007: Chief Investigator A, FiRST grant. A medical treatment for Cataracts ($2 million over 5 years)
- 2003-2005: Chief Investigator A, Royal Society of NZ Marsden award. Conformationally constrained and immobilised bioactives ($600,000).
- 2004-2006: Chief Investigator B, Royal Society of NZ Marsden award. Behaviour, attachment and detachment of algal propagules in turbulent conditions ($700,000).
- 2006 –2008: Chief Investigator A, Royal Society of NZ Marsden award. ‘To beta or not to beta that is the question’ ($850,000)
Relocated to the University of Adelaide (April 2007)
- 2007 – 2009: Chief Investigator A, ARC Discovery grant DP077190. Mimicking peptide structure - towards an aqueous environment (A$300,000).
- 2008 - 2009: Chief Investigator A, ARC International Fellowship grant LX0881950. Conformationally constrained and immobilized beta-peptides (A$119,000).
- 2008 - 2010: Chief Investigator A, ARC Linkage International grant LX0881949. The synthesis and applications of aqueous metathesis. (A$38,000 over 3 years).
- 2009: Chief Investigator, ARC Lief grant LE0989336. South Australian Facility for Small and Large Molecule X-ray Diffraction Structure Determination (A$560,000)
- 2008 - 2009: Chief Investigator, Commercial Accelerator Scheme funding (A$250,000)
- 2009 - 2010: Chief Investigator NHMRC development grant. Proof of concept studies on a novel antibiotic. (A$195,000).
- 2009 – 2012: Chief Investigator A, ARC Discovery grant DP0985176. Electron transfer in proteins, a study of mechanism and function. (A$350,000).
- 2010: Chief Investigator, Cancer Council SA. Restoration of p53 activity in tumours: A new approach involving the p53 coactivator. (A$90,000).
- 2010: Chief Investigator, Cancer Council SA. Antagonists of Gankyrin as anti-cancer agents. (A$84,000)
- 2010: A lead academic for Australian Government HEEF funding to establish a centre for Photonics and Surface Science University of Adelaide (A$28.8 million).
- 2010-2011: Chief Investigator, International Science Linkages (ISL). Finding new medicines for important infectious diseases. (A$198,581)
- 2010-2013: Chief Investigator, ARC Super Science fellowship FS100100039. Disruptive approaches to biological sensing. (A$834,000)
- 2011: Chief Investigator, ARC Lief LE110100169. UV-VIS-IR Spectroscopic Ellipsometers for Advanced Material and Device Characterisation. (A$300,000)
- 2011: University of Queensland Business School Enterprize award to Calpain Therapeutics ($100,000)
- 2011-2014: Chief Investigator, Cancer CRC PhD top up scholarship. Proteasomal inhibitors as anti-cancer agents. (A$30,000).
- 2011-2014: Chief Investigator A. NHMRC Project grant APP1011806. Inhibitors of biotin protein ligase: A new class of antibiotic targetting Staphylococcus aureus. (A$585,000)
- 2011-2015: Chief Investigator, ARC Linkage LP110200736. Nanosampling sensors for real‑time embryo monitoring (A$420,000)
- 2012-2016: Chief Investigator A, ARC DP. Defining peptide structure and function: The shape of things to come (A$355,000).
- 2013-2017: Chief Investigator A, ARC DP130101827. Advancing New Pharmaceuticals (A$360,000)
- 2013: Chief Investigator A, ARC Lief LE130100168. Adelaide NMR Centre (A$1.250 million)
- 2014-2017 Chief Investigator A. NHMRC Project grant APP106885. A new class of antibiotic (A$725,000)
- 2014-2017 Chief Investigator. NHMRC Project grant APP106885. The mechanism of cataract and its prevention. (A$688,000)
- 2014-2021: Chief Investigator, ARC CE140100003. ARC Centre of Excellence for Nanoscale BioPhotonics. (A$40,000,000)
- 2016: University of Adelaide Beacon Research equipment grant ($100,000)
- 2017: Chief Investigator, Channel 7 Research Foundation. Designed Antibiotics Targeting Drug-Resistant and Latent Tuberculosis (181614) ($75,000)
- 2017: Chief Investigator in collaboration with SAHMRI. Faculty of Health and Medical Sciences Research Committee Project Development Grant. Novel tools for imaging intestinal inflammation in-vivo ($30,000)
- 2017: A. D. Abell. University of Adelaide Priority Partner travel grant
- 2017: R. Kostecki, J. Thompson, A. D. Abell, H. Ebendorff-Heidepriem. University of Adelaide Commercial Accelerator Grant. Clinical Device for Measuring Fertilisation Success during IVF treatment ($30,000)
- 2018-: Chief Investigator A, ARC DP180101581. Bio-Inspired Molecular Electronics: From Nanoscience to Nanotechnology (A$415,000)
- 2018-: Chief Investigator. Premiers Research and Industry Fund Research Consortia Program. Research Consortium Program for Agricultural Product Development ($5 million).
- 2021-. Australian Research Council (ARC) Linkage Infrastructure. Abell (CIA). Revitalizing Facilities for Nuclear Magnetic Resonance in South Australia. ($2,450,000)
- 2021. University of Adelaide Commercial Accelerator Grant. Abell (CI) 2021. Development of Pathalogy Activated Drugs for Treatment of Neuropathic Pain ($20,000)
- 2023 Heart Foundation, with C. Bursill (SAHMRI). Plaque-targeted Nrf2 activation using a novel switchable fumarate drug to prevent atherosclerosis ($150,000)
- DIGI FAME Strategy Grant. Verjans, Abell (CI), Liao. Accelerating Drug Discovery with Machine Learning ($20,000)
- 2022-26: NIH Grant (USA). Development of Pathology-activated Drugs for Treatment of Neuropathic Pain. USA $8 million
TEACHING AND CURRICULUM DEVELOPMENT: UNDERGRADUATE
I have a proven ability to teach at all levels across the disciplines of chemistry and biochemistry, having done so at the Universities of Canterbury and Adelaide. I gained considerable experience in the development of new curricula and initiatives as the Head of Biochemistry at the University of Canterbury and also the Head of School of Chemistry and Physics and Chemistry Honours Coordinator at Adelaide as detailed earlier. During my tenure at Canterbury, the discipline of biochemistry grew and evolved significantly, with a number of new courses and initiatives. The end result was a highly successful and extended range of lecture and practical courses, with many students subsequently filtering into postgraduate study. During my time at the University of Canterbury, we also developed new courses on Biological and Pharmaceutical Chemistry and new stand-alone laboratory courses at 2nd and 3rd year. This was a somewhat radical, but ultimately highly successful initiative. More recently as Head of School of Chemistry and Physics and also Chemistry Honours Coordinator at Adelaide I have led the development and evolution of the School’s extended teaching programs in Biological and Medicinal Chemistry and also our Honours and Masters programs.
TEACHING AND SUPERVISION: POSTGRADUATE
I first became aware of the significant opportunities that tertiary education provides while visiting the University of Adelaide during my final year of high school. Prior to this I was unaware that universities existed. I have kept this sense of infinite possibility and opportunity throughout my subsequent career, with a profound desire to share my excitement with as wider an audience as possible. I am motivated to make a difference as an educator, with a passion to engage and inspire students to pursue postgraduate research studies and support strong outcomes. My passion in fostering education is also evident through formal mentoring of early career researchers (ECRs) in Chemistry, Physics, Biochemistry, Engineering, Medical Science, Law and elsewhere. This has resulted in the personal growth of ECR postgraduate practice and more specifically, supportive joint supervision of PhD students across faculties and the wider university and beyond.
My influence at the postgraduate level is considerable and international, having >250 successful postgraduate, research honours, masters, and postdoctoral fellow supervisions (including >80 PhD students) in the last 25 years, with a number of PhD students receiving local, national and international awards as detailed below. This includes jointly supervised PhD students across international institutions, most recently the Universities of Strasbourg, Copenhagen, Tokyo, Cambridge, Canterbury and Lincoln. In the last 5 years alone, I have supervised >30 PhD, 8 Masters, 15 honours students and 25 postdoctoral fellows and I currently hold mentor supervisory status. I enjoy PhD supervisory roles nationally, with joint students from the University of South Australia and the University of Newcastle. PhD graduates from my research group have gone onto occupy influential postdoctoral and commercial positions around the globe in the UK, Ireland, Germany, USA, New Zealand, Japan, Switzerland, Belgium, Singapore, Sweden, Denmark, South Africa, Australia and elsewhere. I always provide strong pastoral support and am proud to say that I have only had a couple of students not complete their studies, all because of health-related issues.
The research activities of my research group are extensive and diverse, with a large collaborative base that spans a range of disciplines with formal supervisions in chemistry, biochemistry, pharmacology, physics, photonics, health sciences, chemical engineering and statistics. This is exemplified by my key role as Adelaide node director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) which provides a world-class environment and uniquely trans-disciplinary experience for contemporary postgraduate study and career progression. It also facilitates the development and implementation of key policy and opportunity across an extended postgraduate student base. This multidisciplinary environment and educational opportunity, is greatly enhanced through commercialisation activity and interest within the CNBP, the Institute for Photonics and Advanced Sensing (IPAS) and also recently with and ImmunoLogic (USA), and Calpain Therapeutics, a privately-funded biotechnology company that I co-founded in 2011. I am proud of having established an environment that has resulted in my postgraduate students publishing high impact papers and receiving local, national and international accolades, awards and opportunities as discussed further below.
I am intimately involved in local, national and international initiatives to foster and develop post-graduate supervisor practice and initiatives. This is particularly evident as an Australian Fulbright ambassador, a prestigious national appointment and also as lead CI within the CNBP as discussed in more detail below.
- SUPERVISORY PRACTICES THAT SUPPORT OUTSTANDING STUDENT OUTCOMES
Innovative Culture - Multidisciplinary research is a hallmark and central component of my supervisory practice and this provides a highly varied and unique experience for postgraduate study; with ‘real-world’ problems, connections and opportunity. This approach and philosophy to supervision is at the forefront of contemporary science with high-quality outcomes for postgraduate students; including concrete opportunities to work on finding solutions to ‘real’ problems. I also provide a strong link into the commercialisation of research and associated career opportunities through, for example, my role with the CNBP and Calpain Therapeutics as mentioned above. As the Adelaide node director of the CNBP, we have developed a number of initiatives to facilitate high quality research outputs including (1) an annual Publications Masterclass (2018 – 2019) held across all national nodes where students bring their working publications that are then developed and progressed individually and in teams; (2) personally leading the development and implementation of new approach to posters presentations within the CNBP at the national and international levels; (3) supporting postgraduates to work with national and international collaborators through visits and video link ups. In fact, we now run a weekly collaborative meeting that brings together all from across the national and international base of the centre. New students were supported to visit national nodes of the CNBP at the beginning of their studies to facilitate collaboration and opportunity. All this facilitates thesis outcomes and completions and overall experience. My skills and experiences in this sphere are internationally recognised, with regular requests to examine PhD theses - in the last few years I have been an external examiner of some 10 PhD theses from leading Australian, French, Singapore, and New Zealand Universities. Within this environment, I also provide considerable opportunity and mentorship to early career researchers (ECR), with consequential flow on effects to wider supervisory practices.
Empowering Excellence - I try to foster a highly supportive and productive research culture with extensive networking and collaborative (beyond Academia) opportunities that result in high-quality outputs, while opening doors for personal growth and career development. Greater than 99% of my 300 or so research publications have postgraduate co-authors and more than 75% involve extended collaboration across multiple disciplines.
Past postgraduate students and researchers have achieved considerable international success and influence in both academic and non-academic fields, in part because of their training and experiences within my group. Two postgraduate students received prestigious Alexander von Humboldt Postdoctoral Fellowships to study in Germany, with one now working in the German pharmaceutical industry.
- SUPPORT FOR THE DEVELOPMENT OF STUDENTS AS INDIVIDUALS
As mentioned above, I have had a leading role in creating a unique opportunity-rich research culture and nurturing environment of international standing for postgraduate students at Adelaide, the scale and influence of which rivals many disciplines and institutional centres. I have done much through the CNBP to engage students in broader intellectual life and to develop as independent researchers with a full range of attributes. We develop and run professionally mediated personal development sessions on commercialisation, mental health and wellbeing, pitching and branding research with guest speakers. All this is also at the heart of the Fulbright program, the largest international scholarship program of its kind directed at promoting leadership and cross-cultural understanding. I develop and promote much in this space as an appointed national Fulbright ambassador through annual information presentations, workshops and as a member of the national panel that assesses and awards fellowships. This includes appointing and supporting international Fulbright visitors with meetings and gatherings. These activities culminate ever year with a gala event in the Great Hall at Parliament House in Canberra, an event at which I am always an invited guest and participant. This exposes the Fulbright awardees to high profile national and international leaders including USA ambassador and senior Federal politicians. I represent the Adelaide division at all these activities and events.
Members of my research group work along-side physicists and biologists in a highly collaborative experience of international standing. Postgraduate students are able to flourish and grow, while also developing entrepreneurial experience and ongoing employment opportunities. I remain a senior member of IPAS with formal supervision, mentoring and leadership roles. This, together with the activities of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) provides a unique mix of fundamental science and impact in what is a wonderful and varied environment for postgraduates and their intellectual and career development. Our approaches and technologies have broad applications across biosciences, agriculture and industry processes, and are being translated to the international biomedical and clinical communities. Our most recent endeavours are forging important links with defence and international industry including Biogen USA. Postgraduate students are creating deployable biodevices for use in health, disease management, but also veterinary care, agricultural and food manufacturing and industry processes with a clear emphasis on translation. Our postgraduates are involved at all levels of this endeavour through our established graduate program, and a number I work with have established commercial opportunity and start-up companies. All this creates an environment rich in intellectual freedom, development, and opportunity.
Supporting the development of transferable skills and knowledge - It is increasingly critical to provide students with opportunities to develop broader capabilities and industry experience that are relevant to other career options. Through the CNBP we mentor an extended array of postgraduate students (>75 nation-wide, with some 25 Uni Adel alone) and ECR’s, with specific programs designed to advance collaborative research and career learning. This includes workshops on grant and paper writing (e.g. CNBP publications masterclass workshop for PhD students at Deakin Uni, Oct 2018 and Adelaide Sept 2019), CNBP Entrepreneur Network "Shark Tank", literature reviews, the preparation of talks for conferences, a Mastermind Network that connects CNBP researchers to mentors, an ECR and Graduate Network to support CNBP students in their scientific and transdisciplinary discussions and collaboration, and other career ready activities. I actively encourage postgraduates (and also postdoctoral fellows) to engage with important external programs such as Science Meets Parliament and CSIRO on Prime (a pre-accelerator program run by the CSIRO to help research teams validate their research and discover real world applications, see http://cnbp.org.au/news ). All this provides a broad intellectual base for postgraduate students and their development within my immediate group, but also more widely to all in the CNBP.
Developing national and international postgraduate exchange programs: Institutional level - I have done much to forge and develop international postgraduate linkages to allow extended research student exchanges with France, Denmark, Germany, Japan, UK, China and Singapore. In 2017 I was awarded a University of Adelaide priority grant to spend 4 weeks at the University of Strasbourg as a prestigious visiting Professor.
As mentioned, I have a long association with the Fulbright programme, firstly as the recipient of a senior award to work in the USA for 12 months and most recently as an Australian Fulbright ambassador. This high-profile international position provides a wonderful and rewarding opportunity to fully embrace the ideals of the Fulbright programme. Our goals are to ‘promote extended educational and cultural exchange’ and I present workshops and seminars to promote and educate postgraduate students on associated opportunities thus presented.
I engage closely with an extended group of Australian and American students and Fellows through the Fulbright program and there is no better mechanism to encourage and help advance the life-long career and personal development of our best and brightest postgraduates and ECRs. I always make a point of celebrating the success of ‘Fulbrighters’ by attending the awardees presentations and functions locally and at the Great Hall, Parliament House, Canberra. Another key role of my ambassadorship is to help select Fulbright awardees through interviews at the local and national level, most recently in September this year where we selected two absolutely outstanding postgraduate students as South Australian Fellows and for higher national honours.
Providing national and international postgraduate exchange opportunities: Group level - I have always strongly supported and promoted postgraduate student exchanges, with members of my group spending time at other institutions in Germany (GKSS), Japan (University of Tokyo), China (Beijing Chinese Academy of Sciences), UK (Cambridge) and New Zealand (Universities of Canterbury and Lincoln) and also supporting visits from international students to my research group as discussed above. My research students also spend considerable time at international meetings and conferences and with our collaborators, particularly at the CNBP including RMIT, Macquarie University and international partners. We also host international research students on shorter exchanges, most recently from the University of Copenhagen and the University of Strasbourg, a priority partner institution for the University of Adelaide as discussed above.
Mentoring students in their career development following completion - I spend much time with postgraduate students and following their graduation as Early Career Researchers (ECRs), to help develop grant and fellowship applications, an area in which I am able to provide much experience having been on the ARC College. As a head of School of Physical Sciences, I was particularly passionate about promoting gender equality and diversity within its postgraduate community and I have always been a willing presenter to postgraduate and ECR’s at Faculty and research branch, and also led ARC panel and educational meetings. All this is enhanced through my role as an Australian Fulbright ambassador, where I actively promote and mentor national and international postgraduate and academic staff leaders through the extended activities of the Fulbright program as discussed above. This is a highly rewarding, influential, and privileged appointment and opportunity; with profound direct and indirect impact on postgraduate students with added ECR involvement.
3. CONTRIBUTIONS TO THE DEVELOPMENT OF EXCELLENT SUPERVISION PRACTICES
I have always been very much motivated by supporting and mentoring postgraduate and early career researchers (ECRs), with a goal to enhance supervisory practice and opportunity. I work closely with up and coming ECRs through my role as Adelaide Node Director CNBP and also with IPAS and while a member of University Council, to help develop supervisory skills and opportunities and this is in fact one of my real passions.
Other key outcomes have been achieved through my roles as Head of the School of Physics and Chemistry at the University of Adelaide (2014/15), ARC College of Experts (2012-14), postgraduate coordinator for the discipline of chemistry (ongoing), University Council, and perhaps most significantly through the Faculty of Science mentoring program. I was a passionate participant in the Faculty of Science ECR mentoring program since its inception, working closely to specifically help develop their career prospects, including supervisory practice and opportunity.
I am highly involved at the Faculty and University levels to support postgraduate initiatives and opportunities. For example, I have represented the CNBP, the Science Faculty and the University on visits to Vietnam and extensively through China, particularly to develop linkages around traditional Chinese Medicine. Helping to host a high-level delegation from Vietnam in 2013 sowed the seeds for this activity. I have also participated in University sanctioned visits to China to build linkages, particularly ECRs with two joining us for 6 months. As part of the University of Adelaide delegation in Vietnam (2015), to engage leading schools and institutions, I undertook an extended series of presentations and engagements with the best and brightest students and teachers. The Chinese work culminated with three ECRs visiting our laboratory, each for 6 months. They receive exposure to world-class multidisciplinary research as well as gain experience in postgraduate supervision and ECR development. Our visitors also provide reciprocal opportunities for our postgraduate students and ECR's.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2026 | Principal Supervisor | Oxidative Stress Activated Prodrugs of Monomethyl Fumarate for the Treatment of Disease | Master of Research | Master | Full Time | Miss Faye Liu |
| 2025 | Principal Supervisor | 1,2-Dicarbonyl ROS-Activated Prodrugs | Doctor of Philosophy | Doctorate | Full Time | Mr Thomas Owen Ward |
| 2025 | Principal Supervisor | Development and optimisation of tumour vasculature modifying agents to improve drug delivery and enhance treatment outcomes in myeloma | Doctor of Philosophy | Doctorate | Full Time | Miss Teena Elise Siapkas |
| 2025 | Co-Supervisor | Enabling blue osmotic–green hydrogen energy coupling | Doctor of Philosophy | Doctorate | Full Time | Mr Zixiong Li |
| 2025 | Principal Supervisor | Development and optimisation of tumour vasculature modifying agents to improve drug delivery and enhance treatment outcomes in myeloma | Doctor of Philosophy | Doctorate | Full Time | Miss Teena Elise Siapkas |
| 2025 | Principal Supervisor | 1,2-Dicarbonyl ROS-Activated Prodrugs | Doctor of Philosophy | Doctorate | Full Time | Mr Thomas Owen Ward |
| 2025 | Co-Supervisor | Enabling blue osmoticgreen hydrogen energy coupling | Doctor of Philosophy | Doctorate | Full Time | Mr Zixiong Li |
| 2024 | Principal Supervisor | New practical applications for an old peptide antibiotic. | Doctor of Philosophy | Doctorate | Full Time | Mr Yifei Wang |
| 2024 | Principal Supervisor | New practical applications for an old peptide antibiotic. | Doctor of Philosophy | Doctorate | Full Time | Mr Yifei Wang |
| 2023 | Principal Supervisor | The Design and Synthesis of New Antimicrobial Agents Based on Biotin Biology | Doctor of Philosophy | Doctorate | Full Time | Ms Taylah Renee Cruse |
| 2023 | Co-Supervisor | Rational Design and Advanced Engineering of High-Quality Nanoporous Photonic Crystal Structures | Doctor of Philosophy | Doctorate | Full Time | Mr Jairo Alberto Baron Jaimez |
| 2023 | Principal Supervisor | The development of radiopharmaceutical therapies using lead-212 | Doctor of Philosophy | Doctorate | Full Time | Mr Jarred Michael Scaffidi-Muta |
| 2023 | Co-Supervisor | Rational Design and Advanced Engineering of High-Quality Nanoporous Photonic Crystal Structures | Doctor of Philosophy | Doctorate | Full Time | Mr Jairo Alberto Baron Jaimez |
| 2023 | Principal Supervisor | The development of radiopharmaceutical therapies using lead-212 | Doctor of Philosophy | Doctorate | Full Time | Mr Jarred Michael Scaffidi-Muta |
| 2023 | Principal Supervisor | The Design and Synthesis of New Antimicrobial Agents Based on Biotin Biology | Doctor of Philosophy | Doctorate | Full Time | Ms Taylah Renee Cruse |
| 2022 | Co-Supervisor | Engineering of light-matter interactions in semiconductor structures for photocatalysis | Doctor of Philosophy | Doctorate | Full Time | Mr Van Truc Ngo |
| 2022 | Co-Supervisor | Bioinspired Engineering of Iontronic Membranes for Osmotic Energy Generation | Doctor of Philosophy | Doctorate | Full Time | Miss Khanh Nhien Vu |
| 2022 | Co-Supervisor | Engineering of light–matter interactions in hybrid plasmonic–photonic crystal structures | Doctor of Philosophy | Doctorate | Full Time | Miss Nguyen Que Huong Tran |
| 2022 | Co-Supervisor | Engineering of light-matter interactions in semiconductor structures for photocatalysis | Doctor of Philosophy | Doctorate | Full Time | Mr Van Truc Ngo |
| 2022 | Co-Supervisor | Bioinspired Engineering of Iontronic Membranes for Osmotic Energy Generation | Doctor of Philosophy | Doctorate | Full Time | Miss Khanh Nhien Vu |
| 2022 | Co-Supervisor | Engineering of lightmatter interactions in hybrid plasmonicphotonic crystal structures | Doctor of Philosophy | Doctorate | Full Time | Miss Nguyen Que Huong Tran |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 - 2025 | Principal Supervisor | Chemical and Computational Strategies to Redesign the Antimicrobial Peptide Gramicidin S | Doctor of Philosophy | Doctorate | Full Time | Mr John Trevor Kalyvas |
| 2021 - 2025 | Co-Supervisor | Harnessing Light–Matter Interactions in Nanoporous Photonic Crystal Structures for Gas Sensing | Doctor of Philosophy | Doctorate | Full Time | Mr Khoa Tran |
| 2020 - 2024 | Co-Supervisor | Insights into Peptidomimetic Approaches for Inhibiting the DNA Sliding Clamps | Doctor of Philosophy | Doctorate | Full Time | Miss Bethiney Chantel Vandborg |
| 2020 - 2025 | Co-Supervisor | Engineering of Light-Emitting Nanoporous Photonic Crystals | Doctor of Philosophy | Doctorate | Full Time | Mr Satyathiran Gunenthiran |
| 2020 - 2025 | Co-Supervisor | Engineering the Iontronic Properties of Nanoporous Anodic Alumina and Its Applications | Doctor of Philosophy | Doctorate | Full Time | Miss Juan Wang |
| 2019 - 2023 | Principal Supervisor | The Design, Synthesis and Evaluation of a New Class of Antibiotic | Doctor of Philosophy | Doctorate | Full Time | Dr Damian Stachura |
| 2019 - 2021 | Principal Supervisor | Targeting PCNA with Cell and Nuclear Permeable p21- derived Peptides | Master of Philosophy | Master | Full Time | Miss Theresa Chav |
| 2018 - 2020 | Principal Supervisor | Probing a Promiscuous Binding Pocket of the Proteasome | Master of Philosophy | Master | Full Time | Mr Dion Joel Lammas Turner |
| 2018 - 2022 | Principal Supervisor | Proteins as Therapeutic Targets in Ovulation, Cancer and Antibiotic Resistance | Doctor of Philosophy | Doctorate | Full Time | Mr Rouven Becker |
| 2018 - 2023 | Principal Supervisor | Small Molecules Targeting Novel Mycobacterium tuberculosis Drug Targets | Doctor of Philosophy | Doctorate | Full Time | Mr Nicholas Charles Schumann |
| 2017 - 2021 | Co-Supervisor | Synthetic, Biomimetic and Chemoenzymatic Studies of Meroterpenoid Natural Products | Doctor of Philosophy | Doctorate | Full Time | Miss Lauren Ashleigh Marie Murray |
| 2017 - 2021 | Co-Supervisor | Progress towards the Biomimetic Total Synthesis of Meroterpenoid Natural Products | Doctor of Philosophy | Doctorate | Full Time | Ms Stefania Sassnink |
| 2017 - 2021 | Principal Supervisor | Approaches to study protein interactions | Doctor of Philosophy | Doctorate | Full Time | Miss Aimee Jade Horsfall |
| 2017 - 2020 | Principal Supervisor | Controlling Peptide Structure and Function | Doctor of Philosophy | Doctorate | Full Time | Miss Yuan Qi Yeoh |
| 2017 - 2025 | Principal Supervisor | Optimising photopharmacology for future clinical applications | Doctor of Philosophy | Doctorate | Part Time | Miss Kathryn Angela Palasis |
| 2017 - 2021 | Co-Supervisor | Mass Spectrometric Methods for the Analysis of Chemically Modified Proteins | Doctor of Philosophy | Doctorate | Full Time | Miss Katherine Stevens |
| 2017 - 2020 | Principal Supervisor | Towards Synthesis of a Novel Chelator for Zirconium-89 | Master of Philosophy | Master | Full Time | Mr Padraig Lorcan Fyfe |
| 2017 - 2021 | Principal Supervisor | Fluorescent sensor development through surface functionalisation | Doctor of Philosophy | Doctorate | Full Time | Mr Patrick Keith Capon |
| 2017 - 2020 | Co-Supervisor | Advanced Photonic Crystals for Efficient Light-Trapping in Photocatalytic Applications | Doctor of Philosophy | Doctorate | Full Time | Miss Siew Yee Lim |
| 2016 - 2018 | Principal Supervisor | Inhibition of Serine and Cysteine Proteases by Peptidomimetic Inhibitors | Master of Philosophy | Master | Full Time | Mr Nicholas Charles Schumann |
| 2016 - 2021 | Co-Supervisor | MASS SPECTROMETRY-BASED STRUCTURAL INSIGHTS INTO PROTEIN ASSEMBLIES | Doctor of Philosophy | Doctorate | Part Time | Mr Henry Michael Sanders |
| 2016 - 2019 | Co-Supervisor | Advanced Engineering of Nanoporous Anodic Alumina Photonic Crystals for Optical Sensing Applications | Doctor of Philosophy | Doctorate | Full Time | Dr Cheryl Suwen Law |
| 2016 - 2018 | Co-Supervisor | Harnessing P450 Enzymes as Biocatalysts for Selective C-H Bond Hydroxylation | Master of Philosophy | Master | Full Time | Dr Joel Hoong Zhang Lee |
| 2015 - 2017 | Principal Supervisor | The Synthesis of Bimane Constrained Peptides and their Fluorescent and Structural Properties | Master of Philosophy | Master | Full Time | Miss Aimee Jade Horsfall |
| 2015 - 2019 | Principal Supervisor | Development of New Antibiotics Based on Biotin Biology | Doctor of Philosophy | Doctorate | Full Time | Mr Kwang Jun Lee |
| 2014 - 2016 | Principal Supervisor | Utilising CYP199A4 from Rhodopseudomonas Palustris HaA2 for Biocatalysis and Mechanistic Studies | Master of Philosophy | Master | Full Time | Miss Rebecca Chao |
| 2014 - 2017 | Co-Supervisor | Biomimetic Total Synthesis of Natural Products | Doctor of Philosophy | Doctorate | Full Time | Mr Hiu Chun Lam |
| 2014 - 2017 | Co-Supervisor | Design and Synthesis of Protein Chemical Crosslinkers: A Modular Approach | Master of Philosophy | Master | Full Time | Miss Kayla Monique Downey |
| 2014 - 2017 | Co-Supervisor | Targeted Therapies for the Treatment of Solid Cancers | Doctor of Philosophy | Doctorate | Full Time | Dr Alaknanda Emery |
| 2014 - 2018 | Principal Supervisor | Sensing in Biological Systems | Doctor of Philosophy | Doctorate | Full Time | Dr Georgina Maree Sylvia |
| 2014 - 2019 | Principal Supervisor | Investigations into the Divergent, Biogenically Inspired Synthesis of Structurally Related Natural Products | Doctor of Philosophy | Doctorate | Full Time | Adrian Webster Markwell-Heys |
| 2013 - 2017 | Co-Supervisor | Development of Biotin Protein Ligase Inhibitors as New Antibiotics to Treat Staphylococcus aureus | Doctor of Philosophy | Doctorate | Full Time | Miss Ashleigh Susan Paparella |
| 2013 - 2017 | Co-Supervisor | In Vitro and In Vivo Characterization of Staphylococcus Aureus Biotin Protein Ligase Transcriptional Repressor Function | Doctor of Philosophy | Doctorate | Full Time | Miss Jiulia Nurannisa Satiaputra |
| 2012 - 2016 | Principal Supervisor | Biomimetic Synthesis of Meroterpenoid Natural Products Using Dearomatization Strategies | Doctor of Philosophy | Doctorate | Full Time | Henry Patrick Pepper |
| 2012 - 2016 | Principal Supervisor | Hydrogen Peroxide Sensing for Reproductive Health | Doctor of Philosophy | Doctorate | Full Time | Dr Malcolm Stuart Purdey |
| 2012 - 2016 | Principal Supervisor | Development of Biotin Protein Ligase Inhibitors from Staphylococcus Aureus as New Antibiotics | Doctor of Philosophy | Doctorate | Full Time | Mr Jiage Feng |
| 2012 - 2016 | Principal Supervisor | Biomimetic Synthesis of Natural Products via Reactions of Ortho-Quinone Methides | Doctor of Philosophy | Doctorate | Full Time | Justin Thomas James Spence |
| 2011 - 2017 | Principal Supervisor | Photoswitchable Sensors: Reversible Ion Detection using Optical Fibres | Doctor of Philosophy | Doctorate | Full Time | Mr Daniel Brian Stubing |
| 2011 - 2015 | Principal Supervisor | PEPTIDOMIMETIC PROTEASE INHIBITORS: ACTIVITY AND MECHANISM OF INHIBITION | Doctor of Philosophy | Doctorate | Part Time | Dr Xiao Zhou Zhang |
| 2011 - 2015 | Principal Supervisor | The Effects of Macrocyclic Constraints on Electron Transfer in Peptides | Doctor of Philosophy | Doctorate | Full Time | Dr John Robert Horsley |
| 2011 - 2018 | Principal Supervisor | A Study on Side Chain Linked Peptides, Toward the Development of Talin Inhibitors using B3 Integrin Peptide Analogues | Doctor of Philosophy | Doctorate | Part Time | Miss Kelly Lee Keeling |
| 2009 - 2013 | Co-Supervisor | Exploring the Structure-Function Relationship of Biotin Protein Ligase from Staphylococcus aureus: Implications for Selective Inhibitor Design | Doctor of Philosophy | Doctorate | Full Time | Dr Tatiana Soares da Costa |
| 2009 - 2014 | Principal Supervisor | A study on the interactions of synthetic IGF-II analogues with the type 1 IGF and insulin receptors | Doctor of Philosophy | Doctorate | Part Time | Miss Jade Misty Cottam |
| 2008 - 2013 | Principal Supervisor | Defining Peptide Structure with Metathesis | Doctor of Philosophy | Doctorate | Full Time | Ms Krystle Chua |
| 2008 - 2012 | Principal Supervisor | New Peptide based Templates Constrained into a Beta-Strand by Huisgen Cycloaddition | Doctor of Philosophy | Doctorate | Full Time | Mr Ashok Dattatray Pehere |
| 2008 - 2011 | Principal Supervisor | ß-Strand Mimicry as the Basis for a Universal Approach to Protease Inhibition | Doctor of Philosophy | Doctorate | Full Time | Mr Seth Adam Jones |
| 2008 - 2013 | Principal Supervisor | Design, synthesis and testing of conformationally constrained peptidomimetics | Doctor of Philosophy | Doctorate | Part Time | Miss Joanna Duncan |
| 2007 - 2012 | Principal Supervisor | Design and Synthesis of Reaction Intermediate Derivatives as Biotin Protein Ligase Inhibitors | Doctor of Philosophy | Doctorate | Full Time | Dr William Tieu |
| 2006 - 2010 | Co-Supervisor | Synthesis of Glutamate Mimics as Neuropathic Pain Modulating Agents | Doctor of Philosophy | Doctorate | Full Time | Dr Nathan Stanley |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2023 - ongoing | Principal Supervisor | Chemistry | The University of Adelaide | - | Honours | - | Bide Di |
| 2023 - ongoing | Principal Supervisor | Chemistry | The University of Adelaide | - | Master | - | Yifei John Wang |
| 2022 - ongoing | Principal Supervisor | Chemistry | The University of Adelaide | - | Master | - | Jarred Michael Scaffidi-Muta |
| 2022 - ongoing | Principal Supervisor | Chemistry | The University of Adelaide | - | Master | - | John Trevor Kalyvas |
| 2022 - ongoing | Principal Supervisor | Chemistry | The University of Adelaide | - | Postdoctorate | - | Dr Damian Stachura |
| 2018 - ongoing | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Thomas Avery |
| 2018 - 2018 | Co-Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Kate Wegener |
| 2018 - 2018 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Damian Stachura |
| 2018 - 2018 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Bianca Jong |
| 2018 - 2018 | External Supervisor | Biological Chemistry | University of Copenhagen | - | Master | Full Time | Dounia Krouch |
| 2017 - 2017 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Thomas Almond |
| 2016 - 2017 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Malcolm Purdey |
| 2016 - 2017 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Niels Krogsgaard-Larsen |
| 2016 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Lina Geng |
| 2016 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Amanpreet Chahal |
| 2016 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Yuan Qi Yeoh |
| 2016 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Stephen Kirby |
| 2016 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Lauren Murray |
| 2016 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Kathryn Palasis |
| 2016 - 2016 | Co-Supervisor | Biological Chemistry | University of Adelaide | - | Master | Full Time | Joel Lee |
| 2015 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Aniket Kulkarni |
| 2015 - 2015 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Ashok Pehere |
| 2015 - 2015 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Nathan Stanley |
| 2015 - 2015 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Vincent Donohue |
| 2015 - 2015 | Co-Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Irene Willcocks |
| 2015 - ongoing | Principal Supervisor | Chemistry | The University of Adelaide | - | Postdoctorate | - | Dr John Horsley |
| 2014 - 2017 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Borja Lopez |
| 2014 - 2017 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Beatriz Blanco Rodríguez |
| 2014 - 2016 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Part Time | Dr Kelly Keeling |
| 2014 - 2014 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr John Horsley |
| 2014 - 2014 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Jenny Butler |
| 2014 - ongoing | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Michelle Zhang |
| 2014 - ongoing | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Victoria Peddie |
| 2014 - 2014 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Sarah Clark |
| 2014 - 2014 | Co-Supervisor | Biological Chemistry | University of Adelaide | - | Master | Full Time | Stephen Tulip |
| 2013 - 2013 | Co-Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Benjamin Keiller |
| 2013 - 2013 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Alexandra Marrone |
| 2013 - 2013 | External Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | David Armstrong |
| 2012 - 2013 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Ondrej Zvarec |
| 2012 - 2012 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Ross Tieman |
| 2012 - 2012 | Co-Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Angie Jarrad |
| 2012 - 2012 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Malcolm Purdey |
| 2012 - 2012 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Tim Engler |
| 2011 - 2014 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr William Tieu |
| 2011 - 2011 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Xiaozhou (Michelle) Zhang |
| 2010 - 2010 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Jiage Feng |
| 2010 - 2010 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Daniel Stubing |
| 2009 - ongoing | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Denis Scanlon |
| 2009 - ongoing | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Jingxian Yu |
| 2009 - 2017 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Sabrina Heng |
| 2009 - 2009 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Kelly Keeling |
| 2008 - 2009 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr James Gardiner |
| 2008 - ongoing | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Steven Polyak |
| 2008 - 2008 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Kim Mitchel |
| 2008 - 2008 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Honours | Full Time | Kevin Kuan |
| 2007 - 2018 | Principal Supervisor | Biochemistry | The University of Adelaide | - | Postdoctorate | - | Steven Polyak |
| 2007 - 2012 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Joanna Duncan |
| 2007 - 2011 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Hongyuan Chen |
| 2007 - 2010 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Blair Stuart |
| 2007 - 2009 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Shazia Zaman |
| 2007 - 2009 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Steven Ballet |
| 2007 - 2008 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Markus Pietsch |
| 2007 - 2008 | Principal Supervisor | Biological Chemistry | University of Adelaide | - | Postdoctorate | Full Time | Dr Daniel Sejer Pedersen |
| 2007 - 2008 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Tarek Millar |
| 2006 - 2010 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Victoria Peddie |
| 2006 - 2007 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Andrew Muscroft-Taylor |
| 2006 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Shigeru Miyamoto |
| 2006 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Blair Stuart |
| 2006 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Victoria Peddie |
| 2006 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Joanna Duncan |
| 2005 - 2007 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Nathan Alexander |
| 2005 - 2007 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | David Pearson |
| 2005 - 2007 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Kelly Anderson |
| 2005 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Wilford Lie |
| 2005 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Mutita Klanchantra |
| 2005 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Hongyuan Chen |
| 2005 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Aimee Zhang |
| 2004 - 2008 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Matt Jones |
| 2004 - 2007 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Janna Nikkel |
| 2004 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Stephen McNabb |
| 2004 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Mary Gower |
| 2004 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Anna McCarthy |
| 2004 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Nathan Alexander |
| 2004 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Tom Cain |
| 2004 - 2004 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | David Pearson |
| 2004 - 2004 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Kelly Anderson |
| 2004 - 2004 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Seth Jones |
| 2003 - 2007 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Paula Brooksby |
| 2003 - 2006 | Co-Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Hannah Lee |
| 2003 - 2006 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Steve Aitken |
| 2003 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Christine Le Sann |
| 2003 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Axel Neffe |
| 2003 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Andrea Vernall |
| 2003 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Barbara Thompson |
| 2003 - 2004 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Barbara Thompson |
| 2003 - 2003 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Anna McCarthy |
| 2003 - 2003 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Jennifer Gadd |
| 2003 - 2003 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Emma Turner |
| 2002 - 2005 | External Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Richard Payne |
| 2002 - 2005 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Shazia Zaman |
| 2002 - 2004 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Florian Graichen |
| 2002 - 2004 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Karina Brown |
| 2002 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Matt Rosenberg |
| 2002 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Andrea Vernall |
| 2002 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Andrea Vernall |
| 2002 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Mary Gower |
| 2002 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Janna Nikkel |
| 2001 - 2001 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Richard Payne |
| 2001 - 2001 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Hayden Peacock |
| 2000 - 2003 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | James Gardiner |
| 2000 - 2003 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Derek Martyn |
| 2000 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Kelly Smith |
| 2000 - 2002 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Emma Turner |
| 2000 - 2001 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Kristian Giles |
| 2000 - 2000 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Karina Brown |
| 2000 - 2000 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Jenny Malmström |
| 1999 - 2001 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Mark Humphries |
| 1999 - 2001 | Co-Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Scott Bringans |
| 1999 - 2001 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Alison Daines |
| 1999 - 2000 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Tim May |
| 1999 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | James Gardiner |
| 1999 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Derek Martyn |
| 1999 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Kelly Smith |
| 1998 - 2001 | Co-Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Kristian Giles |
| 1998 - 2000 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Andrew Harvey |
| 1998 - 2000 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Barnaby May |
| 1998 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Dr Michael Edmonds |
| 1998 - 1998 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Alison Daines |
| 1997 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Brent Nabbs |
| 1997 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Andy Phillips |
| 1997 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Maureen Price (Ratcliff) |
| 1997 - 1997 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Elizabeth Reid |
| 1997 - 1997 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Seung-Joo Lee |
| 1996 - 1999 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Elizabeth Reid |
| 1996 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Andrew Harvey |
| 1996 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Barnaby May |
| 1996 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Andy Phillips |
| 1996 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Maureen Price (Ratcliff) |
| 1995 - 1998 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Michael Moore |
| 1995 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Fiona Buchanan |
| 1995 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Sangeeta Budia |
| 1995 - 1995 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Blair Henderson |
| 1995 - 1995 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | James Murphy |
| 1995 - 1995 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Brent Nabbs |
| 1994 - 1997 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Mark Oldham |
| 1994 - 1994 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Michael Moore |
| 1993 - 1997 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Deborah Hoult |
| 1993 - 1996 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Glenn Foulds |
| 1993 - 1993 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Mark Oldham |
| 1992 - 1992 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Glenn Foulds |
| 1992 - 1992 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Deborah Hoult |
| 1990 - 1992 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | John Trent |
| 1990 - 1992 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Doctorate | Full Time | Chris Litten |
| 1990 - 1990 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Jane Taylor |
| 1989 - 1989 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Chris Litten |
| 1988 - 1989 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Master | Full Time | Kathy Morris |
| 1988 - 1988 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Honours | Full Time | Emily Jamieson |
| 1987 - 1988 | Principal Supervisor | Biological Chemistry | University of Canterbury | - | Postdoctorate | Full Time | Bruce Clark |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2022 - ongoing | Co-Founder | Scientific Officer | ImmunolLogic | United States |
| 2015 - ongoing | - | University of Adelaide Academic Board | University of Adelaide | - |
| 2015 - 2021 | Member | University of Adelaide Academic Board | University of Adelaide | Australia |
| 2011 - ongoing | - | Chief Scientific Advisor and co-founder of new company, Calpain Therapeutics | - | - |
| 2011 - ongoing | - | Australian Research Council (ARC) College of Experts | - | - |
| 2006 - ongoing | - | 6th European Union Funding Framework panel (Brussels) | - | - |
| 2005 - ongoing | - | Governing Board of NZ Chemical Genetics consortium | - | - |
| 2005 - ongoing | - | Australasian representative to the advisory group of two PACIFICHEM symposia (Hawaii) | - | - |
| 2005 - ongoing | - | New Zealand (MoRST) sponsored delegation to the Riken Institute Japan | - | - |
| 2001 - ongoing | - | International representative to the Australian National Health and Medical Research Council Program Grant Committee (Melbourne Australia) | - | - |
| 2001 - ongoing | - | Royal Society of New Zealand Marsden Physical Sciences and Engineering panel | - | - |
| 2000 - ongoing | - | Australasian representative to the advisory group of two PACIFICHEM symposia (Hawaii) | - | - |
| 2000 - ongoing | - | New Zealand representative to the Australian Peptide Association | - | - |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2023 - ongoing | Member | ARC advisory | Australian Research Council | Australia |
| 2013 - 2014 | Member | University of Adelaide Promotions Committee | University of Adelaide | Australia |
| 2006 - 2007 | Member | University of Canterbury Academic Board | University of Canterbury | New Zealand |
| 2003 - 2023 | Member | New Zealand Representative Australasian Peptide Conference Organising Committee | Australasian Peptide Conference | Australia |
| 2003 - ongoing | Chair | NZIC international Conference | New Zealand Institute of Chemistry | New Zealand |
| 2002 - 2005 | Member | PACIFICHEM symposia (Hawaii) | PACIFICHEM | United States |
| 2002 - 2003 | Advisory Board Member | 5th International Peptide Conference | RACI | Australia |
| 2002 - 2003 | Member | Conference Symposium Manager | 14th International Conference on Organic Chemistry | New Zealand |
| 2001 - 2002 | Advisory Board Member | International Union of Pure and Applied Chemistry Conference | International Union of Pure and Applied Chemistry | United Kingdom |
| 2001 - 2001 | Advisory Board Member | Australian National Health and Medical Research Council Program Grant Committee | NHMRC | Australia |
| 2001 - 2001 | Member | National Health and Medical Research Council | NHMRC | Australia |
| 2000 - 2001 | Advisory Board Member | Pacifichem Cysteine Proteases Symposium | Pacifichem | United States |
| 1999 - 2002 | Chair | Canterbury Branch of the New Zealand Society for Biochemistry and Molecular Biology | New Zealand Society for Biochemistry and Molecular Biology | New Zealand |
| Date | Institution | Department | Organisation Type | Country |
|---|---|---|---|---|
| 2023 - ongoing | Royal Australian Chemical Institute (RACI) | Medicinal Chemistry | Business and professional | Australia |
| 2018 - ongoing | Traditional Chinese Medicine University | TCM | Scientific research | China |
| 2017 - ongoing | The European Federation for Medicinal Chemistry (EFMC) | Medicinal Chemistry | Business and professional | Austria |
| 2016 - 2021 | European Commission | Marie Skłodowska Curie Fellowship Panel | Business and professional | Belgium |
| 2014 - 2014 | Advanced Veterinary Therapeutics | Therapeutics | Business and professional | Australia |
| 2013 - 2013 | Minter Ellison | legal | Business and professional | Australia |
| 2005 - 2007 | Eli Lilly Pharmaceuticals (USA) | Pharmaceuticals and legal | Business and professional | United States |
| 2005 - 2006 | Eli Lilly and Company | Pharmaceuticals | Health services and related | United States |
| 1993 - 1994 | SmthKline Beecham Pharmaceuticals (USA) | Pharmaceuticals | Health services and related | United States |
| 1993 - 1994 | SmithKline Beecham Pharmaceuticals USA | Medicinal Chemistry | Health services and related | United States |
| Date | Event Name | Event Type | Institution | Country |
|---|---|---|---|---|
| 2016 - ongoing | South Australian Teachers conference | Congress | South Australian Teachers | Australia |
| 2001 - 2002 | 14th International Conference on Organic Chemistry | Convention | International Conference on Organic Chemistry | - |
| 1998 - 2004 | New Zealand Chemistry Olympiad | Plenary or general session | New Zealand Chemistry Olympiad | - |
| Date | Case | Institution | Country |
|---|---|---|---|
| 2022 - ongoing | Patent Infringement | Biogen USA | United States |
| 2005 - 2006 | Patent Infringement | Eli Lilly Parmaceuticals (USA) | Australia |
| Date | Engagement Type | Partner Name |
|---|---|---|
| 2022 - ongoing | Research Contract | Immunologic (USA) |
| 2007 - ongoing | Consultant | Calpain Therapeutics |
| 2005 - ongoing | Consultant | Riken Institute Japan - MoRST sponsored |
| 1993 - ongoing | Consultant | SmithKline Beecham Fulbright USA Schools |
| 1993 - ongoing | Consultant | Smith Kline becham (USA) |
| Date | Office Name | Institution | Country |
|---|---|---|---|
| 2021 - ongoing | Chemistry Postgraduate Coordinator | The University of Adelaide | Australia |
| 2021 - ongoing | University of Adelaide Honours Chemistry Coordinator | University of Adelaide | Australia |
| 2016 - ongoing | Fulbright Ambassador | Fulbright | United States |
| 2014 - ongoing | Node Director ARC Centre of excellence | CNBP University of Adelaide | Australia |
| 2013 - 2014 | Head of School of Chemistry and Physics | The University of Adelaide | Australia |
| 2002 - ongoing | Chief Scientific Officer and Co-founder | Calpain Therapeutics | New Zealand |
| 2002 - 2003 | Conference Chair New Zealand Institute of Chemistry (NZIC) National Convention | New Zealand Institute of Chemistry (NZIC) | New Zealand |
| 2002 - ongoing | New Zealand MacDiarmid Institute for Advanced Materials and Nanotechnology | NZ CoRE | New Zealand |
| 2001 - 2002 | Conference Editor for the International Union of Pure and Applied Chemistry | International Union of Pure and Applied Chemistry | United Kingdom |
| 2000 - 2003 | Head of Biochemistry University of Canterbury | University of Canterbury | New Zealand |
| 2000 - 2002 | University of Canterbury head of Biochemistry | University of Canterbury | New Zealand |
| 1999 - 2002 | Chairperson of the Canterbury Branch of the New Zealand Society for Biochemistry and Molecular Biology | Canterbury Branch of the New Zealand Society for Biochemistry and Molecular Biology | New Zealand |
| 1990 - 1993 | Canterbury chairperson | New Zealand Institute of Chemistry (NZIC) | New Zealand |
Connect With Me
External Profiles
